Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Riverain Technologies sends best wishes and gratitude to Heber MacMahon, MB BCh, who is retiring from the University of Chicago Medicine and as one of our clinical advisors. He has practiced radiology for 46 years and has been our clinical advisor for the past 14 years. We have all benefited from his insight, thoracic radiology leadership, published articles in scientific medical journals and book chapters, along with dozens of abstracts and exhibits at the RSNA annual conference.
“We wish Dr. MacMahon well as he starts a new chapter in his life. He has been instrumental to Riverain’s success,” stated Steve Worrell, CEO.